Clinical Trials Directory

Trials / Completed

CompletedNCT02183922

Microencapsulated Fish Oil or Conjugated Linoleic Acid in Metabolic Syndrome

Hypocaloric Diet With or Without Microencapsulated Fish Oil or Conjugated Linoleic Acid on Oxidative Stress and Cardiovascular Risk Factors in Women With Metabolic Syndrome Genotyped for Polymorphisms in the Genes PPAR Gamma 2 (Pro12Ala) and Adiponectin (G276T)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Universidade Federal do Rio de Janeiro · Academic / Other
Sex
Female
Age
30 Years – 45 Years
Healthy volunteers
Accepted

Summary

Our aim was to assess the effects of a hypocaloric diet, including diet fruit jelly with microencapsulated fish oil or conjugated linoleic acid or placebo, on anthropometry, body composition, insulin resistance and lipid profile in women with metabolic syndrome and genotype Pro12Pro in the PPAR gamma 2 gene.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTmicroencapsulated conjugated linoleic acidThe microencapsulated conjugated linoleic acid received light fruit jam with microencapsulated conjugated linoleic acid (3 g/day) during 12 weeks.
DIETARY_SUPPLEMENTmicroencapsulated fish oilThe microencapsulated fish oil group received light fruit jam with microencapsulated fish oil (3 g/day) during 12 weeks.
DIETARY_SUPPLEMENTlight fruit jamThe placebo group received light fruit jam (15 g/day) during 12 weeks.

Timeline

Start date
2008-05-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2014-07-08
Last updated
2014-07-08

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02183922. Inclusion in this directory is not an endorsement.